PTJ
SBBP

Paul Tudor Jones’s Strongbridge Biopharma plc. SBBP Stock Holding History

Paul Tudor Jones’s Portfolio SBBP Stock Details SBBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-1,529,426
Closed -$3.12M – 3239
2021
Q3 		$3.12M Hold
1,529,426
– – 0.05% 462
2021
Q2 		$4.54M Buy
+1,529,426
New +$4.04M 0.09% 258

Paul Tudor Jones's SBBP Position: Q4 2021 in Review

Paul Tudor Jones sold out of Strongbridge Biopharma plc. (SBBP) in Q4 2021, closing a stake of 1,529,426 shares — an estimated $3.12M sold.

Paul Tudor Jones first reported a position in SBBP in Q2 2021 and held it in 2 quarters. The position peaked at $4.54M in Q2 2021. 0 funds tracked by Wall St. Rank hold SBBP as of Q4 2021.

  • Paul Tudor Jones reported no remaining Strongbridge Biopharma plc. position as of Q4 2021 after selling out during the quarter.
  • Paul Tudor Jones sold 1,529,426 Strongbridge Biopharma plc. shares in Q4 2021, an estimated $3.12M.
  • Paul Tudor Jones first reported a position in Strongbridge Biopharma plc. in Q2 2021 and held it in 2 quarters.
  • Paul Tudor Jones's Strongbridge Biopharma plc. position peaked at $4.54M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Strongbridge Biopharma plc. as of Q4 2021.

Based on Tudor Investment Corp's 13F filing for Q4 2021, filed 14 Feb 2022.